Cargando…
Evaluation of the role of kefir in management of non-alcoholic steatohepatitis rat model via modulation of NASH linked mRNA-miRNA panel
Non-alcoholic steatohepatitis (NASH) is the clinically aggressive variant of non-alcoholic fatty liver disease. Hippo pathway dysregulation can contribute to NASH development and progression. The use of probiotics is effective in NASH management. Our aim is to investigate the efficacy of kefir Milk...
Autores principales: | Salah, Noha, Eissa, Sanaa, Mansour, Amal, El Magd, Nagwa M. Abo, Hasanin, Amany Helmy, El Mahdy, Manal M., Hassan, Mohamed Kamel, Matboli, Marwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816104/ https://www.ncbi.nlm.nih.gov/pubmed/36604518 http://dx.doi.org/10.1038/s41598-022-27353-x |
Ejemplares similares
-
mRNA-miRNA-lncRNA Regulatory Network in Nonalcoholic Fatty Liver Disease
por: Matboli, Marwa, et al.
Publicado: (2021) -
Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management
por: Hany, Noha M., et al.
Publicado: (2022) -
Promotive action of 2-acetylaminofluorene on hepatic precancerous lesions initiated by diethylnitrosamine in rats: Molecular study
por: Hasanin, Amany Helmy, et al.
Publicado: (2021) -
Rosavin Ameliorates Hepatic Inflammation and Fibrosis in the NASH Rat Model via Targeting Hepatic Cell Death
por: Albadawy, Reda, et al.
Publicado: (2022) -
Identification of Novel Insulin Resistance Related ceRNA Network in T2DM and Its Potential Editing by CRISPR/Cas9
por: Matboli, Marwa, et al.
Publicado: (2021)